Switzerland-based pharmaceuticals and diagnostics developer Roche has purchased US-based Constitution Medical Investors (CMI) for $220m, as part of its strategy to strengthen its hematology testing portfolio. CMI is a hematology testing ...
Tags: pharmaceuticals, diagnostics
Tokyo-based Solar Frontier - the largest manufacturer of CIS (copper indium selenium) thin-film photovoltaic (PV) solar modules - says that its latest champion module from its flagship gigawatt-scale Kunitomi Plant in Miyazaki, Japan, has ...
Tags: Solar, Electrical, Electronics, solar modules
OPEL Technologies Inc of Toronto, Ontario, Canada – which develops III-V semiconductor devices and processes through US affiliate OPEL Defense Integrated Systems (ODIS Inc) of Storrs, CT, USA – says it has achieved Milestone 6 ...
Tags: Electrical, Electronics
Orion Energy Systems, Inc., a leading power technology enterprise, announced yesterday that it has completed the acquisition of Harris Manufacturing, Inc. and Harris LED, LLC. Harris Manufacturing and Harris LED had specialized in ...
Tags: LED lighting, Lights, Lighting
Teva Pharmaceutical Industries has signed an agreement to purchase pharmaceutical and drug delivery company, MicroDose Therapeutx, to strengthen its respiratory franchise. The deal involves acquisition of all of MicroDose's outstanding ...
US-based Johnson & Johnson has agreed to buy Aragon Pharmaceuticals, a discovery and development company focused on drugs to treat hormonally-driven cancers, for nearly $1bn. As per the acquisition agreeement, an upfront cash payment of ...
Tags: Johnson&Johnson, Medicine
AstraZeneca has agreed to purchase California-based respiratory medication developer, Pearl Therapeutics, in a deal with a total potential cost of up to $1.15bn. As per the definitive agreement signed between both the parties, AstraZeneca ...
Tags: AstraZeneca, Pearl Therapeutics
New Energy Technologies, Inc., developer of the world's first-of-its-kind, see-through technology capable of generating electricity on glass and flexible plastics, announced today that researchers have achieved important device design, ...
Tags: Glass Windows, Construction
Second Genome has signed a microbiome drug discovery deal with Janssen Biotech to advance novel drug targets mediated by the bacterial ecosystem living within the human gut to treat ulcerative colitis. Under the collaboration, Janssen ...
Tags: Microbiome Drug, Medicine
US-based biopharmaceutical company Acadia Pharmaceuticals's glaucoma collaboration partner Allergan has advanced a new additional drug candidate into preclinical development for the treatment of glaucoma. Acadia CEO Uli Hacksell said that ...
Tags: Preclinical Development, Allergan
Lighting manufacturer PhotonStar LED Group has generated £8.7m in sales in 2012, up by 44 per cent when compared to the year before. The company’s 2012 sales rose dramatically from £6.06m in 2011, according to the ...
Tags: Photonstar, Lighting
"No one should suffer or die to make clothing. Just the opposite, they and their families should prosper. That's how it is with our supply chain. "That's how it can be with others. Let's not make this harder than it is. And let's not ...
Tags: Apparel, Accessories
The BBC is to abandon a £98m digital production system and suspend its chief technology officer (CTO), John Linwood, after the organisation's chief executive Tony Hall said it had "wasted a huge amount of licence fee payers' money". ...
Tags: BBC, IT Project, CTO John Linwood
Integrated biopharmaceutical company ThromboGenics has announced the launch of Jetrea in Denmark and Sweden by Alcon, a division of Novartis. Alcon expects to roll out the European Commission approved Jetrea, which is indicated for the ...
AstraZeneca has agreed to acquire Omthera Pharmaceuticals along with novel dyslipidemia treatment in a deal, which has a total potential cost of nearly $443m. As per the deal, AstraZeneca will acquire Omthera for $12.70 per share, or ...
Tags: Pharmaceuticals, Astrazeneca